HIGHLIGHTS
- who: Teresa Lindmayr et al. from the Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria have published the article: Body Weight Counts—Cardioversion with Vernakalant or Ibutilide at the Emergency Department, in the Journal: (JOURNAL)
- what: The aim of this study was to elucidate the impact of body weight on pharmacological cardioversion success comparing weight adapted (Vernakalant) and fixed dose (Ibutilide) pharmacotherapeutic cardioversion regimes. Besides the main focus (cardioversion success depending on body weight), this study also discusses some co-variates, such as effect on QTc time and influence of comorbidities on treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.